Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1186/1479-5876-1-3.

Title:
Cross-reactivity between HLA-A2-restricted FLU-M1:58–66 and HIV p17 GAG:77–85 epitopes in HIV-infected and uninfected individuals | Journal of Translational Medicine
Description:
Background The matrix protein of the influenza A virus and the matrix and capsid proteins of the human immunodeficiency virus (HIV) share striking structural similarities which may have evolutionary and biological significance. These similarities led us to hypothesize the existence of cross-reactivity between HLA-A2-restricted FLU-M1:58–66 and HIV-1 p17 GAG:77–85 epitopes. Methods The hypothesis that these two epitopes are cross-reactive was tested by determining the presence and extent of FLU/GAG immune cross-reactivity in lymphocytes from HIV-seropositive and seronegative HLA-A2+ donors by cytotoxicity assays and tetramer analyses. Moreover, the molecular basis for FLU/GAG cross-reactivity in HIV-seropositive and seronegative donors was studied by comparing lymphocyte-derived cDNA sequences corresponding to the TCR-Ξ² variable regions, in order to determine whether stimulation of lymphocytes with either peptide results in the expansion of identical T-cell clonotypes. Results Here, we report evidence of cross-reactivity between FLU-M1:58–66 and HIV-1 p17 GAG:77–85 epitopes following in vitro stimulation of PBMC derived from either HIV-seropositive or seronegative HLA-A2+ donors as determined by cytotoxicity assays, tetramer analyses, and molecular clonotyping. Conclusion These results suggest that immunity to the matrix protein of the influenza virus may drive a specific immune response to an HLA-A2-restricted HIV gag epitope in HIV-infected and uninfected donors vaccinated against influenza.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Science
  • Education
  • Non-Profit & Charity

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We find it hard to spot revenue streams.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {πŸ”}

cells, flum, gag, peptide, donors, hiv, pbmc, pubmed, article, epitopes, stimulation, crossreactivity, lymphocytes, google, scholar, cas, vitro, donor, hlaa, results, influenza, cell, cytotoxicity, tcell, gel, target, usa, seronegative, tetramer, response, peptides, virus, epitope, clonotypes, memory, effector, crossreactive, hlaarestricted, hivseropositive, analyses, identical, sequence, stimulated, assays, viral, loaded, cytotoxic, south, carolina, shown,

Topics {βœ’οΈ}

highly-active anti-retroviral treatment fitc-labeled anti-cd8 mab anti-hla-a2 antibody-enhancement influenza a-derived flu-m1 t-cell-mediated immune response low-affinity cross-reactive interactions hla-a2-restricted flu-m1 hla-a2-restricted cross-reactivity t-cell-mediated recall response t-cell-mediated cross-reactivity melanoma/melanocyte-derived peptide mart-1 hiv-specific t-cell response tcr-Ξ²-variable gene region hiv-1 envelope-specific cytotoxic becton-dickinson cell analyzer t-cell receptor specificities 77–85 hla-a2-restricted peptides t-cell response directed melanocyte differentiation antigen-reactive article download pdf gc-clamped bcseq2 primer Ξ±Ξ²-t-cell clonality candidate t-cell epitopes identical t-cell clonotypes 58–66-specific t-cell clonotypes open access license flu/gag immune cross-reactivity tcr-Ξ² chain gene influenza a-derived tcr-Ξ² variable regions tcr-Ξ² constant region memory t-cell repertoire separating bead-bound cells sebastiano gattoni-celli virus determinant-specific cytotoxic hla-a2-restricted hla-a2/flu-m1 isolate cross-reactive clonotypes seronegative hla-a2+ donors avi-cea/rf-cea vaccine-based therapy directed identical tcr-Ξ² clonotypes 58–66/hla-a2 monomers conjugated hiv-1-derived p17 gag target cells presenting ctl-mediated cross-reactivity 1 ΞΌg/ml flu-m1 strand rt-pcr kit negative-stranded rna viruses demonstrate hla-restriction performed

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Cross-reactivity between HLA-A2-restricted FLU-M1:58–66 and HIV p17 GAG:77–85 epitopes in HIV-infected and uninfected individuals
         description:The matrix protein of the influenza A virus and the matrix and capsid proteins of the human immunodeficiency virus (HIV) share striking structural similarities which may have evolutionary and biological significance. These similarities led us to hypothesize the existence of cross-reactivity between HLA-A2-restricted FLU-M1:58–66 and HIV-1 p17 GAG:77–85 epitopes. The hypothesis that these two epitopes are cross-reactive was tested by determining the presence and extent of FLU/GAG immune cross-reactivity in lymphocytes from HIV-seropositive and seronegative HLA-A2+ donors by cytotoxicity assays and tetramer analyses. Moreover, the molecular basis for FLU/GAG cross-reactivity in HIV-seropositive and seronegative donors was studied by comparing lymphocyte-derived cDNA sequences corresponding to the TCR-Ξ² variable regions, in order to determine whether stimulation of lymphocytes with either peptide results in the expansion of identical T-cell clonotypes. Here, we report evidence of cross-reactivity between FLU-M1:58–66 and HIV-1 p17 GAG:77–85 epitopes following in vitro stimulation of PBMC derived from either HIV-seropositive or seronegative HLA-A2+ donors as determined by cytotoxicity assays, tetramer analyses, and molecular clonotyping. These results suggest that immunity to the matrix protein of the influenza virus may drive a specific immune response to an HLA-A2-restricted HIV gag epitope in HIV-infected and uninfected donors vaccinated against influenza.
         datePublished:2003-08-14T00:00:00Z
         dateModified:2003-08-14T00:00:00Z
         pageStart:1
         pageEnd:11
         sameAs:https://doi.org/10.1186/1479-5876-1-3
         keywords:
            Human Immunodeficiency Virus
            Influenza
            Seronegative Donor
            Biomedicine
            general
            Medicine/Public Health
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1479-5876-1-3/MediaObjects/12967_2003_Article_3_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1479-5876-1-3/MediaObjects/12967_2003_Article_3_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1479-5876-1-3/MediaObjects/12967_2003_Article_3_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1479-5876-1-3/MediaObjects/12967_2003_Article_3_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1479-5876-1-3/MediaObjects/12967_2003_Article_3_Fig5_HTML.jpg
         isPartOf:
            name:Journal of Translational Medicine
            issn:
               1479-5876
            volumeNumber:1
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Paula M Acierno
               affiliation:
                     name:Medical University of South Carolina
                     address:
                        name:Department of Radiation Oncology, Medical University of South Carolina, Charleston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Danforth A Newton
               affiliation:
                     name:Medical University of South Carolina
                     address:
                        name:Department of Radiation Oncology, Medical University of South Carolina, Charleston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Edwin A Brown
               affiliation:
                     name:Medical University of South Carolina
                     address:
                        name:Department of Medicine, Medical University of South Carolina, Charleston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lou Anne Maes
               affiliation:
                     name:Medical University of South Carolina
                     address:
                        name:Department of Pathology, Medical University of South Carolina, Charleston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:John E Baatz
               affiliation:
                     name:Medical University of South Carolina
                     address:
                        name:Department of Pediatrics, Medical University of South Carolina, Charleston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sebastiano Gattoni-Celli
               affiliation:
                     name:Medical University of South Carolina
                     address:
                        name:Department of Radiation Oncology, Medical University of South Carolina, Charleston, USA
                        type:PostalAddress
                     type:Organization
                     name:Medical University of South Carolina
                     address:
                        name:Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Cross-reactivity between HLA-A2-restricted FLU-M1:58–66 and HIV p17 GAG:77–85 epitopes in HIV-infected and uninfected individuals
      description:The matrix protein of the influenza A virus and the matrix and capsid proteins of the human immunodeficiency virus (HIV) share striking structural similarities which may have evolutionary and biological significance. These similarities led us to hypothesize the existence of cross-reactivity between HLA-A2-restricted FLU-M1:58–66 and HIV-1 p17 GAG:77–85 epitopes. The hypothesis that these two epitopes are cross-reactive was tested by determining the presence and extent of FLU/GAG immune cross-reactivity in lymphocytes from HIV-seropositive and seronegative HLA-A2+ donors by cytotoxicity assays and tetramer analyses. Moreover, the molecular basis for FLU/GAG cross-reactivity in HIV-seropositive and seronegative donors was studied by comparing lymphocyte-derived cDNA sequences corresponding to the TCR-Ξ² variable regions, in order to determine whether stimulation of lymphocytes with either peptide results in the expansion of identical T-cell clonotypes. Here, we report evidence of cross-reactivity between FLU-M1:58–66 and HIV-1 p17 GAG:77–85 epitopes following in vitro stimulation of PBMC derived from either HIV-seropositive or seronegative HLA-A2+ donors as determined by cytotoxicity assays, tetramer analyses, and molecular clonotyping. These results suggest that immunity to the matrix protein of the influenza virus may drive a specific immune response to an HLA-A2-restricted HIV gag epitope in HIV-infected and uninfected donors vaccinated against influenza.
      datePublished:2003-08-14T00:00:00Z
      dateModified:2003-08-14T00:00:00Z
      pageStart:1
      pageEnd:11
      sameAs:https://doi.org/10.1186/1479-5876-1-3
      keywords:
         Human Immunodeficiency Virus
         Influenza
         Seronegative Donor
         Biomedicine
         general
         Medicine/Public Health
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1479-5876-1-3/MediaObjects/12967_2003_Article_3_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1479-5876-1-3/MediaObjects/12967_2003_Article_3_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1479-5876-1-3/MediaObjects/12967_2003_Article_3_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1479-5876-1-3/MediaObjects/12967_2003_Article_3_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1479-5876-1-3/MediaObjects/12967_2003_Article_3_Fig5_HTML.jpg
      isPartOf:
         name:Journal of Translational Medicine
         issn:
            1479-5876
         volumeNumber:1
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Paula M Acierno
            affiliation:
                  name:Medical University of South Carolina
                  address:
                     name:Department of Radiation Oncology, Medical University of South Carolina, Charleston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Danforth A Newton
            affiliation:
                  name:Medical University of South Carolina
                  address:
                     name:Department of Radiation Oncology, Medical University of South Carolina, Charleston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Edwin A Brown
            affiliation:
                  name:Medical University of South Carolina
                  address:
                     name:Department of Medicine, Medical University of South Carolina, Charleston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lou Anne Maes
            affiliation:
                  name:Medical University of South Carolina
                  address:
                     name:Department of Pathology, Medical University of South Carolina, Charleston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:John E Baatz
            affiliation:
                  name:Medical University of South Carolina
                  address:
                     name:Department of Pediatrics, Medical University of South Carolina, Charleston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sebastiano Gattoni-Celli
            affiliation:
                  name:Medical University of South Carolina
                  address:
                     name:Department of Radiation Oncology, Medical University of South Carolina, Charleston, USA
                     type:PostalAddress
                  type:Organization
                  name:Medical University of South Carolina
                  address:
                     name:Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal of Translational Medicine
      issn:
         1479-5876
      volumeNumber:1
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Medical University of South Carolina
      address:
         name:Department of Radiation Oncology, Medical University of South Carolina, Charleston, USA
         type:PostalAddress
      name:Medical University of South Carolina
      address:
         name:Department of Radiation Oncology, Medical University of South Carolina, Charleston, USA
         type:PostalAddress
      name:Medical University of South Carolina
      address:
         name:Department of Medicine, Medical University of South Carolina, Charleston, USA
         type:PostalAddress
      name:Medical University of South Carolina
      address:
         name:Department of Pathology, Medical University of South Carolina, Charleston, USA
         type:PostalAddress
      name:Medical University of South Carolina
      address:
         name:Department of Pediatrics, Medical University of South Carolina, Charleston, USA
         type:PostalAddress
      name:Medical University of South Carolina
      address:
         name:Department of Radiation Oncology, Medical University of South Carolina, Charleston, USA
         type:PostalAddress
      name:Medical University of South Carolina
      address:
         name:Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Paula M Acierno
      affiliation:
            name:Medical University of South Carolina
            address:
               name:Department of Radiation Oncology, Medical University of South Carolina, Charleston, USA
               type:PostalAddress
            type:Organization
      name:Danforth A Newton
      affiliation:
            name:Medical University of South Carolina
            address:
               name:Department of Radiation Oncology, Medical University of South Carolina, Charleston, USA
               type:PostalAddress
            type:Organization
      name:Edwin A Brown
      affiliation:
            name:Medical University of South Carolina
            address:
               name:Department of Medicine, Medical University of South Carolina, Charleston, USA
               type:PostalAddress
            type:Organization
      name:Lou Anne Maes
      affiliation:
            name:Medical University of South Carolina
            address:
               name:Department of Pathology, Medical University of South Carolina, Charleston, USA
               type:PostalAddress
            type:Organization
      name:John E Baatz
      affiliation:
            name:Medical University of South Carolina
            address:
               name:Department of Pediatrics, Medical University of South Carolina, Charleston, USA
               type:PostalAddress
            type:Organization
      name:Sebastiano Gattoni-Celli
      affiliation:
            name:Medical University of South Carolina
            address:
               name:Department of Radiation Oncology, Medical University of South Carolina, Charleston, USA
               type:PostalAddress
            type:Organization
            name:Medical University of South Carolina
            address:
               name:Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Radiation Oncology, Medical University of South Carolina, Charleston, USA
      name:Department of Radiation Oncology, Medical University of South Carolina, Charleston, USA
      name:Department of Medicine, Medical University of South Carolina, Charleston, USA
      name:Department of Pathology, Medical University of South Carolina, Charleston, USA
      name:Department of Pediatrics, Medical University of South Carolina, Charleston, USA
      name:Department of Radiation Oncology, Medical University of South Carolina, Charleston, USA
      name:Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, USA

External Links {πŸ”—}(120)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {πŸ“¦}

  • Crossref

4.87s.